Here's new hope on the horizon for women who suffer from hot flashes, an FDA advisory panel is reviewing two new applications for drugs that have been shown to reduce that common symptom of menopause.
One drug called sefelsa was found to reduce the severity and frequency of hot flashes for at least four weeks. The other drug is paxil. It's already approved for depression and anxiety. But now, it has also shown to be more consistent in the treatment of menopause symptoms.
So far, the only approved treatment for menopause is hormone replacement therapy, which has been linked to an increased risk for breast cancer and stroke. These drugs could be the first non-hormonal treatment for hot flashes.
So this is good news, and we'll keep you posted on that panel and what the FDA decides.
Copyright 2013 KCBD. All rights reserved.